Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Fair Value Measurements - Financial Instruments (Details)

Note 5 - Fair Value Measurements - Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Cash [Member] \| Reported Value Measurement [Member]
Cash and cash equivalents, fair value disclosure	$ 1,693	$ 7,534
Cash [Member] \| Estimate of Fair Value Measurement [Member]
Cash and cash equivalents, fair value disclosure	1,693	7,534
Cash [Member] \| Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents, fair value disclosure	1,693	7,534
Cash [Member] \| Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents, fair value disclosure
Cash [Member] \| Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents, fair value disclosure
Money Market Funds [Member] \| Reported Value Measurement [Member]
Cash and cash equivalents, fair value disclosure		776
Money Market Funds [Member] \| Estimate of Fair Value Measurement [Member]
Cash and cash equivalents, fair value disclosure		776
Money Market Funds [Member] \| Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents, fair value disclosure		776
Money Market Funds [Member] \| Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents, fair value disclosure
Money Market Funds [Member] \| Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents, fair value disclosure
Reported Value Measurement [Member] \| Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents, fair value disclosure	1,693
Reported Value Measurement [Member] \| Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents, fair value disclosure
Reported Value Measurement [Member] \| Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents, fair value disclosure
Reported Value Measurement [Member] \| US Treasury Securities [Member]
Investments, fair value disclosure		1,115
Reported Value Measurement [Member] \| Marketable Securities, Money Market Funds [Member]
Investments, fair value disclosure		48
Reported Value Measurement [Member] \| Mutual Funds [Member]
Investments, fair value disclosure		58
Reported Value Measurement [Member] \| Government Agency Securities [Member]
Investments, fair value disclosure		131
Reported Value Measurement [Member] \| Asuragen [Member]
Contingent consideration, deferred payments	3,247	4,628
Reported Value Measurement [Member] \| RedPath [Member]
Contingent consideration, deferred payments	14,653	13,921
Reported Value Measurement [Member]
Cash and cash equivalents, fair value disclosure	1,693	8,310
Investments, fair value disclosure		1,352
Contingent consideration, deferred payments	17,900	18,549
Estimate of Fair Value Measurement [Member] \| US Treasury Securities [Member]
Investments, fair value disclosure		1,115
Estimate of Fair Value Measurement [Member] \| Marketable Securities, Money Market Funds [Member]
Investments, fair value disclosure		48
Estimate of Fair Value Measurement [Member] \| Mutual Funds [Member]
Investments, fair value disclosure		58
Estimate of Fair Value Measurement [Member] \| Government Agency Securities [Member]
Investments, fair value disclosure		131
Estimate of Fair Value Measurement [Member] \| Asuragen [Member]
Contingent consideration, deferred payments	3,247	4,628
Estimate of Fair Value Measurement [Member] \| RedPath [Member]
Contingent consideration, deferred payments	14,653	13,921
Estimate of Fair Value Measurement [Member]
Cash and cash equivalents, fair value disclosure	1,693	8,310
Investments, fair value disclosure		1,352
Contingent consideration, deferred payments	17,900	18,549
Fair Value, Inputs, Level 1 [Member] \| US Treasury Securities [Member]
Investments, fair value disclosure		1,115
Fair Value, Inputs, Level 1 [Member] \| Marketable Securities, Money Market Funds [Member]
Investments, fair value disclosure		48
Fair Value, Inputs, Level 1 [Member] \| Mutual Funds [Member]
Investments, fair value disclosure		58
Fair Value, Inputs, Level 1 [Member] \| Government Agency Securities [Member]
Investments, fair value disclosure		131
Fair Value, Inputs, Level 1 [Member] \| Asuragen [Member]
Contingent consideration, deferred payments
Fair Value, Inputs, Level 1 [Member] \| RedPath [Member]
Contingent consideration, deferred payments
Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents, fair value disclosure		8,310
Investments, fair value disclosure		1,352
Contingent consideration, deferred payments
Fair Value, Inputs, Level 2 [Member] \| US Treasury Securities [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 2 [Member] \| Marketable Securities, Money Market Funds [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 2 [Member] \| Mutual Funds [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 2 [Member] \| Government Agency Securities [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 2 [Member] \| Asuragen [Member]
Contingent consideration, deferred payments
Fair Value, Inputs, Level 2 [Member] \| RedPath [Member]
Contingent consideration, deferred payments
Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents, fair value disclosure
Investments, fair value disclosure
Contingent consideration, deferred payments
Fair Value, Inputs, Level 3 [Member] \| US Treasury Securities [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 3 [Member] \| Marketable Securities, Money Market Funds [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 3 [Member] \| Mutual Funds [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 3 [Member] \| Government Agency Securities [Member]
Investments, fair value disclosure
Fair Value, Inputs, Level 3 [Member] \| Asuragen [Member]
Contingent consideration, deferred payments	3,247	4,628
Fair Value, Inputs, Level 3 [Member] \| RedPath [Member]
Contingent consideration, deferred payments	14,653	13,921
Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents, fair value disclosure
Investments, fair value disclosure
Contingent consideration, deferred payments	$ 17,900	$ 18,549